INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER
Clinical trials for INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER explained in plain language.
Never miss a new study
Get alerted when new INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER trials appear
Sign up with your email to follow new studies for INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Lab-Grown tumor organoids could guide bladder cancer treatment
Disease control OngoingThis trial tests whether lab-grown miniature tumors, called organoids, can help choose the best chemotherapy for people with intermediate-risk bladder cancer. Tumor samples are taken during surgery and grown in the lab. After testing several drugs on the organoids, the most effec…
Matched conditions: INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE2 • Sponsor: Roland Seiler-Blarer • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New virus therapy aims to keep bladder cancer from returning
Disease control OngoingThis early-stage trial tests a treatment called CG0070, a virus-based therapy given directly into the bladder, after standard surgery for intermediate-risk non-muscle invasive bladder cancer. About 20 participants will receive the treatment to see if it is safe and helps prevent …
Matched conditions: INTERMEDIATE RISK NON-MUSCLE INVASIVE BLADDER CANCER
Phase: PHASE1 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC